³Ô¹ÏÍøÕ¾

Does methamphetamine use cause Parkinson’s?

The Conversation

The South Australian government is planning to roll out a new about the impact of using , including crystal methamphetamine or “ice” and powdered methamphetamine or “speed”.

Authors


  • Nicole Lee

    Professor at the ³Ô¹ÏÍøÕ¾ Drug Research Institute (Melbourne), Curtin University


  • Steven Bothwell

    Consultant and Adjunct Associate Lecturer, University of Newcastle

The campaign includes warning messages on pizza boxes – presumably because young people are the group most likely to try methamphetamine and they also eat lots of pizza.

It’s based on from a few years ago that illicit use of methamphetamine and Parkinson’s disease.

The researchers looked at in after methamphetamine use and say they look similar to those in Parkinson’s patients.

But what does the research really tell us about the link? And will pizza box messages prevent these types of harm?

Is there a link between methamphetamine use and Parkinson’s?

Parkinson’s disease is a brain disease that progressively gets worse and has no cure. The key feature is deterioration of neurons that manage the amount of dopamine in a part of the brain, called the . Symptoms start to show when have been damaged.

This part of the brain is responsible for controlling movement as well as the production of the neurotransmitter .

Dopamine is the feel good neurochemical and part of the reward pathway in the brain. Every time we do something pleasant – like eating, sex, listening to music – our brain releases a little bit of dopamine to make us feel good and remind us to do it again. Dopamine is also needed for lots of other functions including and .

Methamphetamine triggers the release of much larger amounts of dopamine than most other activities, which is where its intense pleasurable effects come from. But over time, with regular methamphetamine use, the brain’s receptors become less sensitive. results. Then the effects of the drug are not as strong, or you need to use more to get the same effect.

We already know regular methamphetamine use causes changes in brain (what the brain looks like) and (how the brain works). And that those changes are similar to those seen in Parkinson’s patients.

But as far as we know, unlike Parkinson’s Disease, the changes after using methamphetamine are temporary and in most cases the brain resets itself back to normal functioning once use stops or becomes less frequent.

Is the link a causal one?

A number of animal and human studies have shown between people who have a history of methamphetamine use and the later development of Parkinson’s disease in older age.

Studies have shown that people in treatment for methamphetamine problems are up to to times more likely to develop Parkinson’s disease.

Person looks out of their apartment window
We still don’t know whether methamphetamine causes Parkinson’s.

However, it’s hard to work out whether one causes the other because the numbers of people with both methamphetamine use and Parkinson’s disease are very small.

The estimate of methamphetamine use is around of Australians), and the number of people who develop Parkinson’s disease () is relatively small.

The large majority of people who use methamphetamine generally use only and for a short period in their lifetimes. So even if there is an increased risk of developing Parkinson’s disease, the population risk is quite small.

Studies like those from the , that take a snapshot in time and look at the correlation of two events, aren’t able to tell us whether , only that they are related in some way.

So we don’t know whether methamphetamine causes Parkinson’s disease.

To really work out whether methamphetamine use causes Parkinson’s disease a is needed. A longitudinal study would track people from say childhood to older age and measure their brain structure and function over time to see whether there is higher rate of Parkinson’s disease among people who have used methamphetamine compared to those who haven’t.

Other potential explanations

It’s possible that short term brain changes from using methamphetamine have some longer term impact that make someone more vulnerable to developing a range of disorders later in life, including Parkinson’s disease.

But there may also be other explanations for the link.

For example, people who use methamphetamine regularly are more likely to have (because the drug reduces feelings of hunger), more likely to have , and are at higher risk of . These factors might affect the brain in ways that make the development of Parkinson’s disease more likely.

plays a major role in Parkinson’s disease and also in the development of drug problems. So there might be a common genetic link.

It’s also worth noting that other drugs, and a range of common prescription drugs like medicines for treating psychotic disorders, depression, high blood pressure and epilepsy, also of Parkinson’s disease.

And the pizza boxes?

We know mass media campaigns for issues that affect a relatively small number of people are . Targeted campaigns for people at risk of developing problems .

Peperoni pizza
Pizza-box messaging is unlikely to work.

Drug use is one of the issues for which public campaigns are largely ineffective. In fact, they can actually increase problems by creating stigma. This makes people to seek help for their drug problems.

So the pizza box idea is unlikely to have much impact at all.

Money wasted on these types of campaigns would be much better spent on evidence-based interventions. These include addressing the social problems that increase the risk of using methamphetamine such as poverty and childhood trauma, effective at school, harm reduction programs and .

If you are worried about your own or someone else’s drug use you can call the ³Ô¹ÏÍøÕ¾ Alcohol and other Drug Hotline on 1800 250 015 for advice, counselling or help finding a treatment provider.

The Conversation

Nicole Lee works as a consultant in the alcohol and other drug sector and a psychologist in private practice. She has previously been awarded funding by Australian and state governments, NHMRC and other bodies for evaluation and research into alcohol and other drug prevention and treatment.

Steven Bothwell does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

/Courtesy of The Conversation. View in full .